Vanco AUC Conversion Toolkit 📝 Download Now →

VANCOMYCIN MODELS

Simplify vancomycin AUC dosing
and workflows.

Transition to AUC-based dosing with peace of mind using the only HITRUST CSF certified Bayesian dosing platform.

Scroll to discover our models

Work faster, not harder.

Therapeutic drug monitoring of vancomycin can be a laborious and time-consuming process. There are a lot of moving parts (not to mention spreadsheets). What’s more, updated AUC guidelines for vancomycin dosing are changing the way you work. That’s why finding efficiencies in your workflow can make a big difference to patient care.

Our clinically validated vancomycin drug models and easy-to-use platform, mean you can spend less time on calculations – and more on your patients.

Clinically validated vancomycin models and AUC calculations made simple.

Vancomycin dosing and monitoring support for adults.

Standard Adult

Buelga et al. (2005)

Ideal for individualized dosing from just one drug concentration.

A one-compartment population model derived from a retrospective study on over 200 patients receiving vancomycin treatment for a range of indications. It is a first order elimination model that has been used in over 10,000 patients and has been clinically validated in several publications.

Available Calculations

AUC24 / AUC24:MIC / Trough Only

Complex & Critically Ill Adult

Goti et al. (2018)

Accurate estimation of AUC fitting to both distribution and elimination phases.

A two-compartment, zero-order absorption model derived from a retrospective study with a diverse cohort of over 1,800 patients. It is particularly useful for AUC-based dosing as it fits a more complex pharmacokinetic curve that models the distribution and elimination phases of vancomycin.

Available Calculations

AUC24 / AUC24:MIC / Trough Only

Intermittent Hemodialysis Adult

Goti et al. (2018)

Supports dosing calculation for patients on high-flux, intermittent hemodialysis.

This model has been extrapolated from the two-compartment Goti et al. model which included over 300 patients on high-flux, intermittent hemodialysis. The primary dosing target in this patient population is a pre-dialysis serum concentration which can be used as a surrogate for AUC dosing.

Available Calculations

Pre-dialysis Level / AUC24 / AUC24:MIC

Enhanced Obese Adult

Sabourenkov et al. (2019)

Supports dosing calculations for patients with Class I, II, and III obesity.

This is a one-compartment, zero-order model developed and validated using 2,993 courses of vancomycin administered to patients with a body mass index (BMI) greater than 30 kg/m2. It demonstrated high predictive ability and negligible bias across all three obesity categories.

Available Calculations

AUC24 / AUC24:MIC / Trough Only

Vancomycin dosing and monitoring support for pediatrics and neonates.

Pediatric & Adolescent

Lamarre et al. (2000)

Clinically validated model on pediatric and adolescent populations.

A two-compartment, zero order absorption model with age, sex, total body weight, and creatinine clearance as covariates as described in Lamarre et. al.

Patients Supported

Age: 0 – 18 years

Available Calculations

AUC24 / AUC24:MIC / Trough Only

Preterm & Neonate

Frymoyer et al. (2014)

Supports dosing of preterm neonates from as young as 22 weeks gestation.

This one-compartment, zero-order absorption model includes total body weight (TBW), serum creatinine, gestational age, and postmenstrual age as covariates as described in Frymoyer et. al.

Patients Supported

Age: 0 – 6 months

Available Calculations

AUC24 / AUC24:MIC / Trough Only

Here’s how we’ve been able to help others

“I really can’t stress enough how happy we are with our decision to utilize a Bayesian support tool and specifically DoseMeRx. They were instrumental in the implementation of AUC dosing.”

Dustin Orvin | PharmD

St. Joseph’s/Candler Clinical Pharmacist in Internal Medicine

“Easy to use and effective. Team is prompt, responsive and customer focused.”

Tony Lai | BPharm, GradDipClinPharm, MClinPharm, MSHPA

Senior Pharmacist | Antimicrobial Stewardship | The Children’s Hospital at Westmead, Australia

I’m excited in this modern era that Bayesian dosing software like DoseMeRx makes it possible to apply best clinical practices at the beside. There’s no better way to merge my research focus and clinical knowledge than to lead their clinical advisory board.”

Tom Lodise | PharmD, PhD

Professor at the Albany Pharmacy College of Health Sciences and Clinical Pharmacy Specialist at the Stratton VA Medical Center

“I have been very pleased with the support provided by the DoseMeRx team. They provided us with ample background data, frequent live training sessions, and prompt on-demand support, even on evenings and weekends.”

Robert Smith | PharmD, BCGP, BCPS, FASCP

Senior Director of Health Outcomes and Research | Neil Medical Group

Will Musick

“It’s a straight-forward way to implement AUC-based decision making in Vancomycin dosing whilst at the same time minimizing the number of levels needed. It’s a win-win… DoseMeRx solves my need.”

William L. Musick | Pharm. D., BCPS

Residency Program Director | Houston Methodist

Supporting you in delivering high-quality evidence-based medicine.

Our team of bioinformaticians, scientists, and clinical pharmacists meticulously select the best clinically-validated PK/PD models for DoseMeRx.

Request a free trial

See how easy DoseMeRx is to operate and integrate into your workday.

Request a free trial below. You can also phone us on +1 (832) 358-3308 or email hello@dosemehealth.com.

Why should you choose DoseMeRx?

trusted by clincians
1:1 customer support

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2021 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.